Assuming winner is required, the following results were found.

  • A 3D view of The Amazing Brain: Shining a Spotlight on Individual Neurons

    allow us to look at the brain in many different ways on many different scales. So, I’m especially pleased to highlight this winner of the initiative’s recent “Show Us Your Brain!” contest. Here you get a close-up look at pyramidal neurons located in the...

    https://mschristian.org/index.php/blog/a-3d-view-of-the-amazing-brain-shining-a-spotlight-on-individual-neurons
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    with final results showing 40% agreeing that injectables were inappropriate and 60% disagreeing, making Zakaria the winner of the burning debate. Print This Page Original link Read More

    https://mschristian.org/index.php/articles/2-uncategorised/8956-ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Better Buy: GlaxoSmithKline vs. Bristol Myers Squibb - Motley Fool

    immunotherapy Opdivo, and immunology drug Orencia. Celgene also brought several new drugs to the table that should be big winners in the future. Reblozyl won Food and Drug Administration (FDA) approval for treating anemia in patients with rare blood...

    https://mschristian.org/index.php/articles/2-uncategorised/10592-better-buy-glaxosmithkline-vs-bristol-myers-squibb-motley-fool
  • Better Buy: GlaxoSmithKline vs. Bristol Myers Squibb - Motley Fool

    immunotherapy Opdivo, and immunology drug Orencia. Celgene also brought several new drugs to the table that should be big winners in the future. Reblozyl won Food and Drug Administration (FDA) approval for treating anemia in patients with rare blood...

    https://mschristian.org/index.php/blog/better-buy-glaxosmithkline-vs-bristol-myers-squibb-motley-fool
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    with final results showing 40% agreeing that injectables were inappropriate and 60% disagreeing, making Zakaria the winner of the burning debate. Print This Page Original link

    https://mschristian.org/index.php/blog/ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today

Results 1 - 5 of 5